首页> 外文期刊>Journal of dermatology and cosmetic. >Comparison of efficacy of topical colloidal silver and topical clotrimazole in the treatment of tinea capitis and tinea corporis: A non-randomized clinical trial
【24h】

Comparison of efficacy of topical colloidal silver and topical clotrimazole in the treatment of tinea capitis and tinea corporis: A non-randomized clinical trial

机译:局部胶体银和局部克霉唑治疗体癣和体癣的疗效比较:一项非随机临床试验

获取原文
           

摘要

>Background and Aim: Dermatophytoses are the infections caused by the fungi that are capable to invade and multiply within keratinized tissues such as the skin, hair and nails. Topical azoles are considered the first-line treatment in dermatophytosis, but systemic therapy may also be required in some cases. Fungal skin infections have become more common in recent years, and injudicious use of conventional drugs has led to emergence of resistant species. This study compared the therapeutic effects of topical colloidal silver with topical clotrimazole in the treatment of ?tinea capitis and tinea corporis. >Methods: In this double blind, non-randomized clinical trial, 40 patients with tinea capitis and tinea corporis were allocated into two groups, receiving either topical colloidal silver?or topical clotrimazole, twice daily for at least 4 weeks. Systemic antifungals were also administreerd if needed. The response to treatment (negative KOH smear and resolved symptoms) was compared between the two groups at the end of the treatment period. >Results: The mean response time was 5.26±1.56 (range: 3-8) ?weeks in colloidal silver receivers and 5.00±2.20 (range: 3-12) weeks in the clotrimazole group (P=0.67).? The response rates were 84.2% in the topical colloidal silver group, and 90.0% in the topical clotrimazole group (P=0.66). None of the patients experienced a side effect. >Conclusion: Topical colloidal silver may be as effective and safe as topical clotrimazole in patients with tinea capitis and tinea corporis. Further studies with larger sample sizes are recommended. >
机译:>背景与目的:皮肤癣菌是由真菌引起的感染,能够侵袭皮肤,头发和指甲等角化组织并在其中繁殖。外用唑类被认为是皮肤癣菌的一线治疗,但在某些情况下可能还需要全身治疗。近年来,真菌皮肤感染已变得更加普遍,常规药物的不当使用导致了耐药菌的出现。这项研究比较了局部胶体银和局部克霉唑在治疗头癣和体癣中的治疗效果。 >方法:在这项双盲,非随机的临床试验中,对40例头癣和肥胖患者进行了研究。体癣被分为两组,分别接受局部胶体银或局部克霉唑,每天两次,至少4周。如果需要,也可以使用全身性抗真菌药。在治疗期结束时比较两组患者对治疗的反应(KOH阴性涂片和症状缓解)。 >结果:平均反应时间为5.26±1.56(范围:3-8)胶体银接受者的治疗周数为几周,克霉唑组为5.00±2.20周(范围:3-12周)(P = 0.67)。局部胶体银组的缓解率为84.2%,局部克霉唑组的缓解率为90.0%(P = 0.66)。结论:外用胶体银对头癣和体癣的治疗效果与局部克霉唑一样有效和安全。建议使用更大样本量进行进一步研究。 >

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号